Regarding energy production by the electron transport chain, which is true?
Cancer cells preferentially utilize glycolysis for energy production even in the presence of adequate oxygen. What is this phenomenon called?
Among the following enzymes, which one produces NADH in the citric acid cycle?
Which of the following metabolic processes is associated with increased Basal Metabolic Rate (BMR)?
Which coenzyme serves as the primary electron acceptor in multiple dehydrogenase reactions of the Kreb's cycle?
Which of the following primarily occurs in the mitochondria?
Which molecule acts as the primary electron carrier in the Krebs cycle?
What is the total number of dehydrogenases involved in the Krebs cycle?
What is the theoretical yield of ATP generated in one TCA cycle?
Which of the following is not a cofactor required by pyruvate dehydrogenase?
Explanation: ***The complexes are arranged in an increasing order of redox potential*** - The electron transport chain complexes are arranged with progressively higher **redox potentials** (also known as reduction potentials) from complex I to complex IV. - This arrangement ensures a **thermodynamically favorable flow of electrons** from components with lower redox potentials to those with higher redox potentials, releasing energy at each step. - This is the **standard scientific description** of ETC organization. *The complexes are arranged in an increasing order of ability to accept electrons* - While higher redox potential does correlate with greater electron-accepting tendency, this is **not the precise terminology** used to describe ETC organization. - The standard biochemical description uses **"redox potential"** or **"reduction potential"** rather than the vague phrase "ability to accept electrons." - This option is **imprecise and non-standard**, making it incorrect in the context of a medical exam. *The complexes are arranged in an increasing order of oxidation state* - The **oxidation state** of the components within the complexes changes dynamically as they accept and donate electrons. - However, the overall arrangement of the complexes is not based on a static "oxidation state" but rather on their **redox potential**. *The complexes are arranged in an increasing order of energy level* - The energy of the electrons **decreases** as they move down the electron transport chain, with energy being released at each step. - This released energy is used to pump protons and generate the electrochemical gradient, not stored in the complexes as an "increasing energy level." - This statement is **factually incorrect** - energy decreases, not increases.
Explanation: ***Warburg*** - The **Warburg effect** describes how cancer cells preferentially use glycolysis for energy production even in the presence of oxygen, allowing them to thrive in **hypoxic conditions** [1]. - This metabolic adaptation supports **cell proliferation** and survival in tumor microenvironments where oxygen is limited [1][3]. - Cancer cells upregulate glucose uptake and express specific metabolic enzymes like the M2 isoform of pyruvate kinase that facilitate this altered metabolism [2][4]. *Wanton* - This term typically refers to recklessness or extravagance and is not used in the context of cancer metabolism or hypoxia. - There are no associations with **cancer cell adaptation** under adverse environmental conditions. *Wormian* - **Wormian bones** are extra bone pieces within sutures of the skull, unrelated to cancer cell metabolism or survival mechanisms. - This term does not connect to **hypoxia** or metabolic adaptations in cancer biology. *Wolf* - "Wolf" has no recognized connection to cancer cell biology, particularly regarding metabolic adaptations under **hypoxic stress**. - It does not imply any concept associated with how cancer cells cope with adverse conditions. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 307-308. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 308-310. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 290-291. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 26-27.
Explanation: ***Isocitrate dehydrogenase*** - This enzyme catalyzes the conversion of **isocitrate to $\alpha$-ketoglutarate**, a reaction that releases **carbon dioxide** and reduces NAD+ to **NADH**. - This is one of the three **irreversible** (rate-limiting) reactions of the citric acid cycle. *Succinate thiokinase* - This enzyme, also known as **succinyl-CoA synthetase**, catalyzes the conversion of succinyl-CoA to succinate. - This reaction produces **GTP** (which can be readily interconverted to ATP), not NADH. *Succinate dehydrogenase* - This enzyme catalyzes the conversion of **succinate to fumarate**. - This reaction reduces **FAD to FADH2**, not NAD+ to NADH. *Fumarase* - This enzyme catalyzes the **hydration of fumarate to malate**. - This reaction does not involve the production of either NADH or FADH2; it simply adds a water molecule.
Explanation: ***Increased glycolysis*** - Among the given options, **increased glycolysis** is the best answer as it represents **active catabolic metabolism** that generates ATP to meet energy demands. - While glycolysis itself doesn't directly increase BMR, **increased glycolytic activity occurs in metabolically active tissues** and reflects higher cellular energy turnover. - Tissues with higher metabolic rates (muscle, brain, liver) have increased glycolysis to meet their ATP demands, making this the most appropriate choice among the options provided. *Increased body fat store* - **Adipose tissue** is metabolically **less active** than lean tissue (muscle, organs). - Increased body fat typically results in a **lower BMR per unit body weight** because fat tissue has minimal metabolic activity compared to muscle. - Greater fat stores are associated with lower, not higher, metabolic rate. *Increased lipogenesis* - **Lipogenesis** (synthesis of fatty acids and triglycerides) is an **anabolic storage process**. - This process occurs during energy surplus and represents a state of **reduced energy expenditure** relative to energy intake. - Storage processes like lipogenesis are associated with **lower overall metabolic activity**, not increased BMR. *Increased glycogenesis* - **Glycogenesis** (synthesis of glycogen from glucose) is an **anabolic storage process** occurring primarily in liver and muscle. - This represents **energy storage**, not energy expenditure, and occurs during fed states when energy demands are being met. - Storage processes do not increase BMR; they indicate surplus energy being stored for later use.
Explanation: ***NAD⁺ (NAD)*** - **NAD⁺ (Nicotinamide Adenine Dinucleotide)** serves as the primary **electron acceptor** in the Kreb's cycle, being reduced to **NADH** in three key dehydrogenase reactions. - These reactions occur at: **isocitrate dehydrogenase**, **α-ketoglutarate dehydrogenase**, and **malate dehydrogenase** steps. - The **NAD⁺/NADH** coenzyme system is essential for extracting energy from acetyl-CoA, with NADH subsequently donating electrons to the **electron transport chain** for ATP synthesis. *NADP* - **NADP⁺ (Nicotinamide Adenine Dinucleotide Phosphate)** is primarily involved in **anabolic reactions**, such as **fatty acid synthesis** and the **pentose phosphate pathway**. - While structurally similar to NAD⁺ (differing only by a phosphate group), it functions in different metabolic pathways and is not utilized in the **Kreb's cycle**. *NADPH* - **NADPH** is the reduced form of **NADP⁺** and functions as a reducing agent in various **biosynthetic pathways**, including synthesis of **fatty acids**, **cholesterol**, and **nucleotides**. - It also plays a crucial role in **antioxidant defense** (glutathione reduction) and the **respiratory burst** in phagocytes. - NADPH is not involved in the **Kreb's cycle**, which uses the NAD⁺/NADH system instead. *NADH* - **NADH** is the **reduced form** of NAD⁺ produced during the Kreb's cycle reactions. - While NADH and NAD⁺ are two forms of the same coenzyme, the question asks for the **electron acceptor** form, which is **NAD⁺** (oxidized form). - **NADH** carries the extracted electrons to **Complex I** of the electron transport chain, where it is reoxidized back to NAD⁺, generating approximately **2.5 ATP** per NADH molecule.
Explanation: ***Correct Option: ETC*** - The **electron transport chain (ETC)** is a series of protein complexes located **exclusively in the inner mitochondrial membrane**. - It occurs **solely in mitochondria** with no cytosolic component, making it the process that most "primarily" occurs in this organelle. - Its primary role is to generate a **proton gradient** through electron transfer, ultimately producing ATP via **oxidative phosphorylation**. - This is the definitive mitochondrial process among the options. *Ketogenesis* - **Ketogenesis** does occur entirely in the **mitochondrial matrix** of liver cells during fasting or low carbohydrate intake. - While mitochondrial, it is tissue-specific (primarily liver) and metabolically conditional (occurs during fasting states). - It involves synthesis of **ketone bodies** (acetoacetate, β-hydroxybutyrate) from acetyl-CoA. *Urea cycle* - The **urea cycle** is compartmentalized between the **mitochondrial matrix** and **cytosol** of liver cells. - First two steps (carbamoyl phosphate synthetase I and ornithine transcarbamylase) occur in mitochondria. - Remaining steps occur in cytosol, so it is NOT primarily mitochondrial. - Functions to detoxify **ammonia** by converting it to urea. *Steroid synthesis* - **Steroid synthesis** primarily occurs in the **smooth endoplasmic reticulum**. - Only specific steps (e.g., cholesterol side-chain cleavage by CYP11A1) occur in mitochondria. - Most of the steroidogenic pathway is extra-mitochondrial.
Explanation: ***NADH*** - **NADH** (reduced nicotinamide adenine dinucleotide) is the **primary electron carrier** produced during the Krebs cycle. - **Three molecules of NADH** are generated per cycle (at isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, and malate dehydrogenase steps). - These high-energy electrons are transferred to the **electron transport chain** to generate approximately **7.5 ATP per NADH**. *NAD+* - **NAD+** (oxidized nicotinamide adenine dinucleotide) is the coenzyme that *accepts* electrons during the Krebs cycle. - It is the **oxidized form** that gets reduced to NADH, not the carrier itself. *FADH₂* - **FADH₂** (reduced flavin adenine dinucleotide) is also produced in the Krebs cycle at the **succinate dehydrogenase** step. - However, only **one molecule of FADH₂** is produced per cycle compared to three NADH molecules. - FADH₂ generates approximately **5 ATP** in the electron transport chain, making NADH the quantitatively dominant electron carrier. *NADPH* - **NADPH** (reduced nicotinamide adenine dinucleotide phosphate) is NOT involved in the Krebs cycle. - It is primarily used in **anabolic pathways** such as fatty acid synthesis, cholesterol synthesis, and the **pentose phosphate pathway**. - NADPH serves as a **reducing agent** in biosynthetic reactions and protects against oxidative stress.
Explanation: ***4*** - There are four major **dehydrogenase enzymes** that catalyze oxidation-reduction reactions in the Krebs cycle. - These enzymes are **isocitrate dehydrogenase**, **α-ketoglutarate dehydrogenase complex**, **succinate dehydrogenase**, and **malate dehydrogenase**. *3* - This count is incorrect as it omits at least one key dehydrogenase involved in the Krebs cycle's oxidative steps. - A count of three would exclude one of the enzymes responsible for generating **NADH** or **FADH2**. *2* - This number is significantly underestimated, as the Krebs cycle involves multiple steps where a substrate is oxidized and a coenzyme is reduced. - Such a low number would fail to account for the multiple points of **NADH** and **FADH2** generation. *5* - This count is incorrect, as there are specifically four well-established dehydrogenase enzymes within the Krebs cycle responsible for the production of **NADH** or **FADH2**. - No additional dehydrogenase beyond the four listed plays a primary role in the canonical Krebs cycle.
Explanation: ***Correct: 10*** - One turn of the **TCA cycle** produces 3 NADH, 1 FADH₂, and 1 GTP (which is equivalent to ATP) - Using modern **P/O ratios**: 3 NADH yield 7.5 ATP (3 × 2.5 ATP/NADH) and 1 FADH₂ yields 1.5 ATP (1 × 1.5 ATP/FADH₂) - Adding the 1 GTP/ATP from substrate-level phosphorylation gives a **total of 10 ATP** *Incorrect: 2* - This only accounts for **substrate-level phosphorylation** (1 GTP converted to ATP) and ignores the substantial ATP generated from NADH and FADH₂ through **oxidative phosphorylation** - The total theoretical yield including electron transport chain is much higher *Incorrect: 8* - This is based on **outdated calculations** using older P/O ratios (3 ATP/NADH and 2 ATP/FADH₂ = 3×3 + 1×2 - 1 = 10, or miscalculation) - Modern biochemistry uses 2.5 ATP per NADH and 1.5 ATP per FADH₂, yielding 10 ATP total *Incorrect: 11* - This **overestimates** the ATP yield, possibly by using incorrect P/O ratios or miscounting the number of reduced cofactors produced - The standard calculation with 3 NADH, 1 FADH₂, and 1 GTP yields exactly 10 ATP
Explanation: ***NAD*** - **NAD+ (Nicotinamide adenine dinucleotide)** is required by the dihydrolipoyl dehydrogenase (E3) component of the pyruvate dehydrogenase complex to accept electrons and form NADH. - This cofactor is crucial for the regeneration of the oxidized lipoamide, allowing the complex to continue its catalytic cycle. *FAD* - **FAD (Flavin adenine dinucleotide)** is also a cofactor for the dihydrolipoyl dehydrogenase (E3) enzyme, accepting electrons from reduced lipoamide before transferring them to NAD+. - It is tightly bound to the E3 enzyme and undergoes reversible oxidation-reduction during the reaction. *Biotin* - **Biotin** is primarily a cofactor for **carboxylase enzymes**, such as pyruvate carboxylase, which catalyzes the conversion of pyruvate to oxaloacetate. - It is **not involved** in the pyruvate dehydrogenase complex reaction, which is an oxidative decarboxylation, not a carboxylation. *CoA* - **Coenzyme A (CoA)** is essential for the pyruvate dehydrogenase complex, as it accepts the acetyl group from pyruvate to form **acetyl-CoA**. - Acetyl-CoA is the product of the reaction and serves as the entry molecule into the **Krebs cycle**.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free